These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14518669)

  • 1. Primary pulmonary hypertension treated with short-term epoprostenol infusion.
    Shiota Y; Mikawa Y; Arikita H; Nakashima T; Horita N; Hiyama J; Ono T; Yamakido M
    Intern Med; 2003 Sep; 42(9):824-6. PubMed ID: 14518669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of primary pulmonary hypertension treated by long-term continuous administration of epoprostenol].
    Yano S; Kobayashi K; Kato K; Tatsukawa T; Ikeda T
    Nihon Kokyuki Gakkai Zasshi; 2005 Jun; 43(6):354-9. PubMed ID: 15997785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of continuous intravenous epoprostenol therapy on advanced primary pulmonary hypertension in Taiwanese patients.
    Hsu HH; Chen JS; Kuo SH; Chiang FT; Ko WJ; Kuo SW; Huang SC; Lee YC
    J Formos Med Assoc; 2005 Jan; 104(1):60-3. PubMed ID: 15660181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension.
    Aguilar RV; Farber HW
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1846-50. PubMed ID: 11069824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
    Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
    J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moderate-term effect of epoprostenol on severe portopulmonary hypertension.
    Kato H; Katori T; Nakamura Y; Kawarasaki H
    Pediatr Cardiol; 2003; 24(1):50-3. PubMed ID: 12574979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of inhaled nitric oxide and intravenous prostacyclin for successful treatment of severe pulmonary hypertension in a patient with ARDS.
    Dahlem P
    Intensive Care Med; 1999 Dec; 25(12):1474-5. PubMed ID: 10660861
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension.
    Kähler CM; Graziadei I; Wiedermann CJ; Kneussl MP; Vogel W
    Wien Klin Wochenschr; 2000 Jul; 112(14):637-40. PubMed ID: 11008327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weaning and discontinuation of epoprostenol in children with idiopathic pulmonary arterial hypertension receiving concomitant bosentan.
    Ivy DD; Doran A; Claussen L; Bingaman D; Yetman A
    Am J Cardiol; 2004 Apr; 93(7):943-6. PubMed ID: 15050507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion.
    Shapiro SM; Oudiz RJ; Cao T; Romano MA; Beckmann XJ; Georgiou D; Mandayam S; Ginzton LE; Brundage BH
    J Am Coll Cardiol; 1997 Aug; 30(2):343-9. PubMed ID: 9247503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension.
    Stiebellehner L; Petkov V; Vonbank K; Funk G; Schenk P; Ziesche R; Block LH
    Chest; 2003 Apr; 123(4):1293-5. PubMed ID: 12684325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension.
    Kuo PC; Johnson LB; Plotkin JS; Howell CD; Bartlett ST; Rubin LJ
    Transplantation; 1997 Feb; 63(4):604-6. PubMed ID: 9047158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of severe pulmonary hypertension associated with COPD treated with epoprostenol].
    Ishikawa S; Yano S; Wakabayashi K; Tokuda Y; Kobayashi K; Ikeda T; Takeyama H
    Nihon Kokyuki Gakkai Zasshi; 2008 Aug; 46(8):660-6. PubMed ID: 18788437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose epoprostenol improved pulmonary hypertension in a patient with systemic lupus erythematosus.
    Matsukawa Y; Igei K; Nozaki T; Ohki T; Shimizu T; Kitamura N; Mitamura K; Takei M; Kasamaki Y; Sawada S
    Clin Rheumatol; 2007 Apr; 26(4):582-3. PubMed ID: 16391888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary hypertension and beta-thalassemia major: report of a case, its treatment, and a review of the literature.
    Tam DH; Farber HW
    Am J Hematol; 2006 Jun; 81(6):443-7. PubMed ID: 16680745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin).
    Higenbottam T; Wheeldon D; Wells F; Wallwork J
    Lancet; 1984 May; 1(8385):1046-7. PubMed ID: 6143976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy and primary pulmonary hypertension : successful outcome with epoprostenol therapy.
    Stewart R; Tuazon D; Olson G; Duarte AG
    Chest; 2001 Mar; 119(3):973-5. PubMed ID: 11243988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidural or I.V.? Tubing trouble.
    Cohen MR
    Nursing; 2008 Jul; 38(7):17. PubMed ID: 18580638
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous epoprostenol treatment of patients with connective tissue disease and pulmonary arterial hypertension at a single center.
    Shirai Y; Yasuoka H; Takeuchi T; Satoh T; Kuwana M
    Mod Rheumatol; 2013 Nov; 23(6):1211-20. PubMed ID: 23359006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral and inhaled prostanoid therapy in the treatment of pulmonary arterial hypertension.
    McLaughlin VV; Palevsky HI
    Clin Chest Med; 2013 Dec; 34(4):825-40. PubMed ID: 24267307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.